Foundation Medicine has launched FoundationOne®RNA, an RNA sequencing test that complements its DNA-based FoundationOne®CDx. This combination provides enhanced fusion...
PathAI, a leader in AI-powered pathology, launches an Early Access Program (EAP) for its AISight Image Management System (IMS)...
CRIO, a leading eSource provider, has secured a substantial investment from The Riverside Company. This funding will accelerate the...
Drug-resistant Acinetobacter baumannii is a significant global health threat, and the World Health Organization (WHO) has classified it as...
Beaconcure Inc., a leader in AI-driven clinical data validation, and Phastar Inc., a biometrics CRO, have partnered to streamline...
Xcellbio and AmplifyBio have partnered to enhance the development and manufacturing of engineered T-cell receptor (TCR) therapies for solid...
Terran Biosciences has developed TerXT, a combination of novel prodrugs of xanomeline and trospium, for treating schizophrenia. The prodrug...
The DIA Europe 2024 conference brought together leading experts to discuss groundbreaking innovations and regulatory strategies in clinical trials....
Parallel Bio, a biotechnology company, has developed “Clinical Trial in a Dish,” a revolutionary platform that employs human models...
Karius, Inc., a pioneer in genomic diagnostics for infectious diseases, has received a Breakthrough Device designation from the FDA...
